Does Maintenance Rucaparib Improve Post-Progression Outcomes in Ovarian Cancer?

Researchers tested maintenance therapy with rucaparib in a phase III trial of patients with recurrent epithelial ovarian cancer who experienced response to platinum-based chemotherapy.

Source: CancerNetwork - June 10, 2019 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news